Targeted Therapies in Lung Cancer 2023
GRACE
Lung Cancer Panel Discussion: Resistance on Targeted Therapy - Questions Patients Should Ask
- 136 views
- September 11, 2023
- 1
GRACE
Targeted Therapies in Lung Cancer 2023: Does Radiation Increase Toxicity for Patients on TT?
- 143 views
- September 11, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: Is Biomarker Testing Common in Early Stage NSCLC?
- 56 views
- September 11, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: Novel Treatment Approaches in Advanced NSCLC - ALK and ROS1+ Disease
FEATURING
Misako Nagasaka
- 176 views
- August 25, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: RET and Other Rare Fusions in NSCLC
FEATURING
Stephen Liu
- 94 views
- August 25, 2023
- 1
GRACE
Targeted Therapies in Lung Cancer 2023: Biomarker Testing for NSCLC - Fundamentals & Challenges
FEATURING
Aakash Desai
- 732 views
- August 25, 2023
- 2
GRACE
Targeted Therapies in Lung Cancer 2023: Non-Metastatic NSCLC and Targeted Therapies
FEATURING
Joshua Reuss
- 131 views
- August 25, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: EGFR Targeted Therapies in NSCLC
FEATURING
Isabel Preeshagul
- 387 views
- August 25, 2023
- 2
GRACE
Targeted Therapies in Lung Cancer 2023: Translating Cancer Discovery - Targeting KRAS G12C in NSCLC
FEATURING
Joshua Sabari
- 148 views
- August 25, 2023
- 1
GRACE
Targeted Therapies in Lung Cancer 2023: Symptom Management and Palliative Care
FEATURING
Laura Petrillo
- 53 views
- August 25, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: The Future of Local Therapy
FEATURING
Puneeth Iyengar
- 16 views
- August 23, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: Barriers to Biomarker Testing - Cost and Insurance
FEATURING
Aakash Desai
- 14 views
- August 23, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: The ADAURA Trial for NSCLC - The Effect on EGFR+ Treatment
FEATURING
Joshua Reuss
- 18 views
- August 22, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: Key Points From the ADAURA Trial - Osimertinib in NSCLC
FEATURING
Joshua Reuss
- 84 views
- August 22, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: Neoadjuvant Treatment for Patients With NSCLC
FEATURING
Joshua Reuss
- 102 views
- August 22, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: Biomarker Driven Therapy for NSCLC
FEATURING
Aakash Desai
- 382 views
- August 22, 2023
- 1
GRACE
Targeted Therapies in Lung Cancer 2023: Current Recommendations and Best Practices for Biomarker Testing in NSCLC
FEATURING
Aakash Desai
- 341 views
- August 22, 2023
- 2
GRACE
Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC
FEATURING
Aakash Desai
- 703 views
- August 22, 2023
- 3
GRACE
Targeted Therapies in Lung Cancer 2023: The Importance of Biomarker Testing in NSCLC - Liquid Biopsy
FEATURING
Aakash Desai
- 112 views
- August 22, 2023
GRACE
Targeted Therapies in Lung Cancer 2023: Barriers to Biomarker Testing - Ordering Tests
FEATURING
Aakash Desai
- 55 views
- August 17, 2023
- 1